OBJECTIVE: To retrospectively review our experience over a 10-year period of renal transplantation in patients with augmented bladders and thus assess the safety of this procedure. PATIENTS AND METHODS: Ten transplant recipients who had previously undergone augmentation cystoplasty were reviewed; a cadaveric kidney was transplant in each case. The donor ureter was anastomosed to the augment bladder in six patients, in three to the native ureter and in one the donor renal pelvis was anastomosed to the native ureter. RESULTS: No patients died and nine of the 10 grafts were functioning at a mean follow-up of 27 months. The mean (SD) serum creatinine level at the follow-up was 100.8 (27.25) mmol/L. Four patients had 10 episodes of urosepsis requiring hospital admission, with only one graft lost. CONCLUSION: Renal transplantation can be performed safely in patients with an augmentation cystoplasty.
OBJECTIVE: To retrospectively review our experience over a 10-year period of renal transplantation in patients with augmented bladders and thus assess the safety of this procedure. PATIENTS AND METHODS: Ten transplant recipients who had previously undergone augmentation cystoplasty were reviewed; a cadaveric kidney was transplant in each case. The donor ureter was anastomosed to the augment bladder in six patients, in three to the native ureter and in one the donor renal pelvis was anastomosed to the native ureter. RESULTS: No patients died and nine of the 10 grafts were functioning at a mean follow-up of 27 months. The mean (SD) serum creatinine level at the follow-up was 100.8 (27.25) mmol/L. Four patients had 10 episodes of urosepsis requiring hospital admission, with only one graft lost. CONCLUSION: Renal transplantation can be performed safely in patients with an augmentation cystoplasty.
Authors: Jin Sun Choi; Hyunmin Ko; Hyo Kee Kim; Chris Chung; Ahram Han; Seung-Kee Min; Jongwon Ha; Sangil Min Journal: Korean J Transplant Date: 2020-10-30
Authors: Inez K B Slagt; Jan N M Ijzermans; Mustafa Alamyar; Paul C M S Verhagen; Willem Weimar; Joke I Roodnat; Türkan Terkivatan Journal: Int Urol Nephrol Date: 2013-02-14 Impact factor: 2.370